1489 STAR-TREC (NCT02945566): A randomised phase II/III trial of CRT versus 5x5 Gy SCRT for organ preservation in early/intermediate risk rectal cancer
Corrie A.M. Marijnen(Leiden University Medical Center), Jacobus W. A. Burger(Radboud University Nijmegen), Femke P. Peters(The Netherlands Cancer Institute), Ian Geh(Queen Elizabeth Hospital Birmingham), Gunnar Baatrup, Nicholas P. West(Griffith University), Karen‐Lise Garm Spindler(Aarhus University Hospital), Alexandra Gilbert(St James's University Hospital), Albert Wolthuis(KU Leuven), David Sebag‐Montefiore(University of Leeds), Karin Haustermans(Radboud University Nijmegen), Victoria Homer(Cancer Research UK Clinical Trials Unit), Stephan Körsgen, Eva Angenete(Sahlgrenska University Hospital), Fabian A. Holman, Geerard L. Beets(The Netherlands Cancer Institute), Anna Martling(Karolinska Institutet), Ane Appelt(University of Leeds), Simon Gates(Oxford Brookes University), Pehr Lind(Karolinska Institutet), Issam Al‐Najami, Mark Teo(St James's University Hospital)
Cited by 8
Related Papers
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial
|The Lancet|2009|1.5k
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection
|JAMA|2010|1.4k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k